Skye Bioscience Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: SKYE
Share price (3/26/26): $0.62
Market cap (3/26/26): $20.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 10-K 79 pages Agreement and Plan of Merger and Reorganization by and Among: Skye Bioscience, Inc., a Nevada Corporation; Aquila Merger Sub, Inc., a Delaware Corporation; and Bird Rock Bio, Inc., a Delaware Corporation Dated as of August 15, 2023

from 8-K 89 pages Plan of reorganization, merger, acquisition or similar

from 8-K 120 pages Arrangement Agreement Between Skye Bioscience, Inc. and Emerald Health Therapeutics, Inc. May 11, 2022

from SC 13D/A 1 page Form of Amendment No. 1 to Promissory Note

from 8-K 21 pages Agreement and Plan of Merger